Skip to main content
. 2024 Jun 14;63(6):857–869. doi: 10.1007/s40262-024-01379-y

Fig. 4.

Fig. 4

a Simulations of patients taking 40 mg QD cabozantinib fasted versus taking 60 mg QD 2 days+1 day skip regimen fasted; b Simulations of patients taking 40 mg QD cabozantinib fasted versus taking 40 mg QD 2 days+1 day skip regimen fed; c Simulations of patients taking 20 mg QD cabozantinib fasted versus taking 40 mg q72h fed (Black line: median simulation curve; shaded area: 90% prediction interval (PI))